FDA.reportPublic FDA data

elinzanetant 60 MG Oral Capsule

RxCUI
2725516
RxNorm name
elinzanetant 60 MG Oral Capsule
Display name
elinzanetant 60 MG Oral Capsule
Full name
elinzanetant 60 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:28

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LYNKUETELINZANETANTBayer HealthCare Pharmaceuticals Inc.f42884ff-7dff-419c-8a0c-affe2ed738182026-06-16Warnings, Adverse reactionsExact identifier
rxcui: 2725516

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
f42884ff-7dff-419c-8a0c-affe2ed73818elinzanetant 60 MG Oral Capsule [PSN] · elinzanetant 60 MG Oral Capsule [SCD]29These highlights do not include all the information needed to use LYNKUET safely and effectively. See full prescribing information for LYNKUET. LYNKUET ® (elinzanetant) capsules, for oral use Initial U.S. Approval: 202520260304